Primary Immune Effects of Eukaryotic Expression Plasmids Encoding Two Hyperactive Mutants of Human Soluble B Lymphocyte Stimulator
- 36 Downloads
B lymphocyte stimulator (BLyS), a ligand belonging to the tumor necrosis factor (TNF) family, plays a critical role in regulating survival and activation of peripheral B cell populations during humeral immune responses. Among the TNF family members, BLyS is unique in that it contains an unpaired Cys residue (Cys146) at the corresponding position where some other members have about 37.5% (6/16) Ala or 37.5% (6/16) Val. Here, with eukaryotic expression vector pcDNA3.1(−), we mutated Cys146 to Ala or Val and constructed two mutant eukaryotic expression plasmids of the human soluble BLyS, pcDNA3.1BY-A and pcDNA3.1BY-V. Following repetitive subcutaneous injection of these expression plasmids in BALb/C mice, the wild-type and mutant BLyS proteins were detectable in the blood of treated animals over several weeks. In addition, the expression of these proteins induced specific IgG but not IgM responses. The implications of the results are discussed.
KeywordsB cell proliferation BLyS cytokine immunoglobulin secretion mutation
Unable to display preview. Download preview PDF.
- 2.Ficara F, Superchi DB, Hernandez RJ, Mocchetti C, Carballido-Perrig N, Andolfi G, Deola S, Colombo A, Bordignon C, Carballido JM, Roncarolo MG, Aiuti A: IL-3 or IL-7 increases ex vivo gene transfer efficiency in ADA-SCID BM CD34+ cells while maintaining in vivo lymphoid potential. Mol Ther 10:1096, 2004CrossRefPubMedGoogle Scholar
- 3.Moore PA, Belvedere O, Orr A, Pieri K, LaFleur DW, Feng P, Soppet D, Charters M, Gentz R, Parmelee D, Li YL, Galperina O, Giri J, Roschke V, Nardelli B, Carrell J, Sosnovtseva S, Ruben SM, Olsen HS, Fikes J, Hilbert DM: BLyS: A member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285:260, 1999CrossRefPubMedGoogle Scholar
- 5.Schneider P, MacKay F, Steiner V, Hofmann K, Bodmer JL, Holler N, Ambrose C, Lawton P, Bixler S, Acha-Orbea H, Valmori D, Romero P, Werner-Favre C, Zubler RH, Browning JL, Tschopp J: BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189:1747, 1999CrossRefPubMedGoogle Scholar
- 11.Schiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, Dobles M, Frew E, Scott ML: An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293:2111, 2001Google Scholar
- 13.Parry TJ, Riccobene TA, Strawn SJ, Williams R, Daoud R, Carrell J, Sosnovtseva S, Miceli RC, Poortman CM, Sekut L, Li Y, Fikes J, Sung C: Pharmacokinetics and immunological effects of exogenously administered recombinant human B lymphocyte stimulator (blys) in mice. J Pharmacol Exp Ther 296:396, 2001PubMedGoogle Scholar
- 18.Chen G, Peng S, Zou M, Wang J: Construction and function of two cysteine146-mutants with high activity, derived from recombinant human soluble B lymphocyte stimulator. J Biochem 136:74, 2004Google Scholar
- 19.Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989Google Scholar
- 20.Vieillard V, Cremer I, Lauret E, Rozenbaum W, Debre P, Autran B, De Maeyer E: Interferon beta transduction of peripheral blood lymphocytes from HIV-infected donors increases Th1-type cytokine production and improves the proliferative response to recall antigens. Proc Natl Acad Sci USA 94:11595, 1997CrossRefPubMedGoogle Scholar
- 21.Martinenghi, S, Cusella De Angelis, G, Biressi, S, Amadio, S, Bifari, F, Roncarolo, MG, Bordignon, C, Falqui, L: Human insulin production and amelioration of diabetes in mice by electrotransfer-enhanced plasmid DNA gene transfer to the skeletal muscle. Gene Ther 9:1429, 2002CrossRefPubMedGoogle Scholar
- 22.Demers GW, Sugarman BJ, Beltran JC, Westreich LN, Ahmed CM, Lau JY, Hong Z, Lanford RE, Maneval DC: Interferon-alpha2b secretion by adenovirus-mediated gene delivery in rat, rabbit, and chimpanzee results in similar pharmacokinetic profiles. Toxicol Appl Pharmacol 180:36, 2002CrossRefPubMedGoogle Scholar